Graham-Little-Piccardi-Lassueur syndrome: a rare case report and review of literature

Authors

  • Rabia Ghafoor
  • Bahram Khan Khoso
  • Muhammad Irfan Anwar
  • Sobia Fawad Hashmi

DOI:

https://doi.org/10.66344/jpad.25.4.2015.156

Keywords:

Graham-Little-Piccardi-Lasseur syndrome, cicatricial alopecia, lichen planopilaris

Abstract

Graham-Little-Piccardi-Lasseur syndrome (GLPLS) is a rare variant of lichen planopilaris comprising of a triad of multifocal cicatricial alopecia of scalp, non-cicatricial alopecia of axillae and pubic region and keratotic follicular papules over body. Its exact etiology is not known to date, but it primarily involves an immune mediated inflammation affecting hair follicles resulting in cicatricial alopecia. We report a case of 55 years old female diagnosed as having features of this syndrome with cicatricial alopecia of FFA and FADP.

References

Assouly P, Reygagne P. Lichen planopilaris: Update on diagnosis and treatment. Semin Cutan Med Surg. 2009;28:3-10.

Graham-Little EG. Folliculitis decalvans et atrophicans. Br J Dermatol. 1915;27:183-5.

Matta M, Kibbi AG, Khattar J et al. Lichen planopilaris: A clinicopathologic study. J Am Acad Dermatol. 1990;22:594-8.

Pai VV, Kikkeri NN, Sori T, Dinesh U. Graham-Little-Piccardi-Lassueur syndrome: an unusual variant of follicular lichen planus. Int J Trichol. 2011;3:28-30.

László FG. Graham-Little-Piccardi-Lasseur syndrome: case report and review of the syndrome in men. Int J Dermatol. 2014;53:1019-22.

Vega Gutierrez J, Miranda-Romero A, Perez Milan F, Martinez Garcia G. Graham-Little- Piccardi-Lassueur syndrome associated with androgen insensitivity syndrome (testicular feminization). J Eur Acad Dermatol Venereol. 2004;18:463-6.

Viglizzo G, Verrini A, Rongioletti F. Familial Lassueur-Graham-Little-Piccardi syndrome. Dermatology. 2004;208:142–4.

Moretti S, Amato L, Massi D et al. Evaluation of inflammatory infiltrate and fibrogenic cytokines in pseudopelade of Brocq suggests the involvement of T-helper 2 and 3 cytokines. Br J Dermatol. 2004;151:84-90.

Bardazzi F, Landi C, Orlandi C et al. Graham Little-Piccardi-Lasseur syndrome following HBV vaccination. Acta Derm Venereol. 1999;79:93.

Vashi N, Newlove T, Chu J et al. Graham- Little-Piccardi-Lassueur syndrome. Dermatol Online J. 2011;17(10):30.

Tchernev G, Nenoff P. Antigen mimicry followed by epitope spreading: A pathogenetic trigger for the clinical morphology of lichen planus and its transition to Graham-Lassueur-Piccardi- Little Syndrome and keratosis lichenoides chronica-Medical hypotheses or reality? An Bras Dermatol. 2009;84:682-8.

Rodriguez-Bayona B, Ruchaud S, Rodriguez C et al. Autoantibodies against the chromosomal passenger protein INCENP found in a patient with Graham Little- Piccardi-Lassueur syndrome. J Autoimmune Dis. 2007;4:1

Abbas O, Chedraoui A, Ghosn S. Frontal fibrosing alopecia presenting with components of Piccardi-Lassueur-Graham- Little syndrome. J Am Acad Dermatol. 2007;57:S15-8.

Zinkernagel MS, Med C, Trüeb RM. Fibrosing alopecia in a pattern distribution: patterned lichen planopilaris or androgenetic alopecia with a lichenoid tissue reaction pattern? Arch Dermatol. 2000;136:205-11.

Bottoni U, Innocenzi D, Carlesimo M. Treatment of Piccardi-Lassueur-Graham Little syndrome with cyclosporin A. Eur J Dermatol. 1995;5:216-9.

Ghislain PD, Van Eeckhout P, Ghislain E. Lassueur-Graham Little-Piccardi syndrome: a 20-year follow-up. Dermatology. 2003;206:391-2.

Downloads

Published

2016-11-26

How to Cite

1.
Ghafoor R, Khoso BK, Anwar MI, Hashmi SF. Graham-Little-Piccardi-Lassueur syndrome: a rare case report and review of literature. J Pak Assoc Dermatol [Internet]. 2016Nov.26 [cited 2026Apr.12];25(4):327-30. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/156

Issue

Vol. 25 No. 4 (2015): October - December

Section

Case Reports

License

Submission declaration

Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.

By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.